COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 1020: Articles 10191-10200  | Next

Vaccine breakthrough and the invasion dynamics of SARS-CoV-2 variants
Saad-Roy, C. M., Levin, S. A., Gog, J. R., Farrar, J., Wagner, C. E., Metcalf, C. J. E., Grenfell, B. T.
10.1101/2021.12.13.21267725 — Posted: 2021-12-14
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
Damijan, J. P., Damijan, S., Kostevc, C.
10.1101/2021.12.12.21267672 — Posted: 2021-12-14
Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study
Chou, O. H. I., Zhou, J., Lee, T. T. L., Kot, T., Lee, S., Wai, A. K. C., Wong, W. T., Zhang, Q., Cheng, S. H., Liu, T., Vassiliou, V. S., Cheung, B. M. Y., Tse, G.
10.1101/2021.12.13.21267730 — Posted: 2021-12-14
Oral antiviral clevudine compared with placebo in Korean COVID-19 patients with moderate severity
Song, J.-Y., Kim, Y.-S., Eom, J.-S., Kim, J.-Y., Lee, J.-S., Lee, J., Choi, W.-S., Heo, J.-Y., Sohn, J.-W., Lee, K.-D., Cho, D., Cho, I., Kim, W.-J.
10.1101/2021.12.09.21267566 — Posted: 2021-12-14
Microarray-based detection of antibodies against SARS-CoV-2 proteins, common respiratory viruses and type I interferons
Savvateeva, E., Filippova, M., Valuev-Elliston, V., Nuralieva, N., Yukina, M., Troshina, E., Baklaushev, V., Ivanov, A., Gryadunov, D.
10.1101/2021.12.13.21267509 — Posted: 2021-12-14
Age-specific Contribution of Contacts to Transmission of SARS-CoV-2 in Germany
Rodiah, I., Vanella, P., Kuhlmann, A., Jaeger, V., Harries, M., Krause, G., Bock, W., Lange, B.
10.1101/2021.12.13.21267716 — Posted: 2021-12-14
Production and secretion of functional full-length SARS-CoV-2 spike protein in Chlamydomonas reinhardtii
Kiefer, A., Niemeyer, J., Probst, A., Erkel, G., Schroda, M.
10.1101/2021.12.13.472433 — Posted: 2021-12-14
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O'Connell, A.-M., Simons, D., Blomquist, P. B., Dabrera, G., Myers, R., Ladhani, S. N., Amirthalingam, G., Gharbia, S., Barrett, J. C., Elson, R., Ferguson, N., Zambon, M., Campbell, C. N., Brown, K., Hopkins, S., Chand, M., Ramsay, M., Lopez Bernal, J.
10.1101/2021.12.14.21267615 — Posted: 2021-12-14
Isolation and Characterization of SARS-CoV-2 strains circulating in Eastern India.
Singh, B., Avula, K., Chatterjee, S., Datey, A., Ghosh, A., De, S., Keshry, S. S., Ghosh, S., Suryawanshi, A. R., Dash, R., Senapati, S., Beuria, T. K., Prasad, P., Raghav, S., Swain, R. K., Parida, A., Syed, G. H., Chattopadhyay, S.
10.1101/2021.12.13.472526 — Posted: 2021-12-14
High temporal resolution transcriptomic profiling delineates distinct patterns of interferon response following Covid-19 mRNA vaccination and SARS-CoV2 infection
Rinchai, D., Deola, S., Zoppoli, G., Kabeer, B. S. A., Taleb, S. A., Pavlovski, I., Maacha, S., Gentilcore, G., Toufiq, M., Matthew, L., Liu, L., Vempalli, F. R., Mubarak, G., Lorenz, S., Sivieri, I., Cirmena, G., Dentone, C., Cuccarolo, P., Giacobbe, D., Baldi, F., Garbarino, A., Cigolini, B., Cremonesi, P., Bedognetti, M., Ballestrero, A., Bassetti, M., Hejblum, B. P., Augustine, T., Panhuys, N. V., Thiebaut, R., Branco, R., Chew, T., Shojaei, M., Short, K., Feng, C., Zughaier, S. M., Maria, A. D., Tang, B., Hssain, A. A., Bedognetti, D., Grivel, J.-C., Chaussabel, D.
10.1101/2021.12.12.472257 — Posted: 2021-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).